This article provides an in-depth description of the France’s CEESP structure and working methods, and analyses the impact of health economic assessment on market access of drugs in France, as well as pointing out the areas of uncertainty and the conflicting rules following the introduction of the health economic assessment. Learn more here. (Source: Journal of Market Access & Health Policy, 2015)
You are here: Home / Cost Effectiveness / What is the Future of Health Economics Assessment of Drugs in France?
